Gaucher disease results from impaired activity of the lysosomal enzyme glucocerebrosidase. Aiming at overexpressing the human glucocerebrosidase and testing the efficiency of the two in-frame ATGs of its gene in directing synthesis of an active enzyme, it was coupled to the T7 RNA polymerase promoter in a vaccinia virus-derived expression vector (pTM-1). cDNAs containing either one or both ATGs of the glucocerebrosidase mRNA were linked to the T7 polymerase promoter. Recombinant viruses were produced and used for infecting human cells in tissue culture. The results demonstrated that both ATGs directed translation of active glucocerebrosidase, resulting in a 10-fold increase in enzymic activity. Most of the protein remained sensitive to endoglycosidase H. The active enzyme represented a small fraction of the expressed glucocerebrosidase. The recombinant enzyme had the same Km and optimal pH towards the artificial substrate 4-methylumbelliferyl glucopyranoside as the authentic endogenous human enzyme. Measurements of intracellular enzymic activity directed by the cDNAs with either one or both ATGs in cells loaded with a fluorescent glucosylceramide demonstrated a 30% increase in activity directed by the cDNAs containing the first ATG over that containing the second ATG. This indicates that the protein synthesized from the first ATG, with a 38 amino acid leader, is translocated through the endoplasmic reticulum more readily than its counterpart directed by the second ATG, with a 19 amino acid leader. The elevation in glucocerebrosidase activity and the reproducibility of the data leads us to propose the use of the vaccinia virus-derived expression system as a tool for studying glucocerebrosidase mutants in Gaucher disease.
Skip Nav Destination
Article navigation
July 1996
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Research Article|
July 01 1996
Overexpression of human glucocerebrosidase containing different-sized leaders
Metsada PASMANIK-CHOR;
Metsada PASMANIK-CHOR
*Department of Cell Research and Immunology, Tel-Aviv University, 69978 Ramat-Aviv, Israel
Search for other works by this author on:
Orna ELROY-STEIN;
Orna ELROY-STEIN
*Department of Cell Research and Immunology, Tel-Aviv University, 69978 Ramat-Aviv, Israel
Search for other works by this author on:
Hans AERTS;
Hans AERTS
†The E. C. Slater Institute, Amsterdam, The Netherlands
Search for other works by this author on:
Vered AGMON;
Vered AGMON
‡Department of Biochemistry, Hebrew University, Hadassah School of Medicine, Jerusalem, Israel
Search for other works by this author on:
Shimon GATT;
Shimon GATT
‡Department of Biochemistry, Hebrew University, Hadassah School of Medicine, Jerusalem, Israel
Search for other works by this author on:
Mia HOROWITZ
Mia HOROWITZ
§
*Department of Cell Research and Immunology, Tel-Aviv University, 69978 Ramat-Aviv, Israel
§To whom correspondence should be addressed.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
August 29 1995
Revision Received:
January 24 1996
Accepted:
February 13 1996
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London © 1996
1996
Biochem J (1996) 317 (1): 81–88.
Article history
Received:
August 29 1995
Revision Received:
January 24 1996
Accepted:
February 13 1996
Citation
Metsada PASMANIK-CHOR, Orna ELROY-STEIN, Hans AERTS, Vered AGMON, Shimon GATT, Mia HOROWITZ; Overexpression of human glucocerebrosidase containing different-sized leaders. Biochem J 1 July 1996; 317 (1): 81–88. doi: https://doi.org/10.1042/bj3170081
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.